The impact of the first COVID-19 surge on severe asthma patients in the UK. Which is worse: the virus or the lockdown?

Asthma therapy, including monoclonal antibodies, was not associated with #COVID19 infection or hospitalisation in a UK severe asthma population. Shielding led to a reported worsening of mental health in nearly half of patients contacted (47%). https://bit.ly/3jImUsG

Detalles Bibliográficos
Autores principales: Smith, Steven J., Busby, John, Heaney, Liam G., Pfeffer, Paul E., Jackson, David J., Yang, Freda, Fowler, Stephen J., Menzies-Gow, Andrew, Idris, Elfatih, Brown, Thomas, Gore, Robin, Faruqi, Shoaib, Dennison, Paddy, Dodd, James W., Doe, Simon, Mansur, Adel H., Priyadarshi, Radhika, Holmes, Joshua, Hearn, Andrew, Al-Aqqad, Hamsa, Loewenthal, Lola, Cooper, Angela, Fox, Lauren, Selvan, Mayurun, Crooks, Michael G., Thompson, Alison, Higbee, Daniel, Fawdon, Michelle, Nathwani, Vishal, Holmes, LeanneJo, Chaudhuri, Rekha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2021
Materias:
Original Research Letters
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7681958/
https://www.ncbi.nlm.nih.gov/pubmed/33564672
http://dx.doi.org/10.1183/23120541.00768-2020
Descripción
Sumario:Asthma therapy, including monoclonal antibodies, was not associated with #COVID19 infection or hospitalisation in a UK severe asthma population. Shielding led to a reported worsening of mental health in nearly half of patients contacted (47%). https://bit.ly/3jImUsG

Ejemplares similares